Member Info for lenlenlen

Thanks guys, I'm going to begin delving a little deeper into the company in the next few weeks as it's been a while since I first got in here and haven't been following too closely. Has anyone got any info about how they've funded some of their bigger projects? The balance sheet looks comfortable at a first glance.

It was around 90p before covid, but that came after some earnings fears, before which it was at 130p. New CEO Steve Francis has some great experience from what I've read about him, especially with turning companies around from underperformance. Quite a few confounding variables, but if they all turn in our favour, could see it getting above 100p again, although that wouldn't be by the end of the year - Although hopefully not far off.

Considering the RTC and therefore ODX got a positive mention in the briefing last night, I will not be selling any shares before 1st June. We obviously may overshoot this deadline a little, but more news will come before then to (hopefully) explain where we're at and how close we are.

I wasn't expecting to see 23 anymore. My average is 24 but holding strong here.

The arrogance and ignorance of some of the members on here is mind boggling. Demanding that the company somehow magic a groundbreaking product out of thin air. You should not be investing if that's your thought process here.

Interested to see if people will twist this into a negative. If you watch the briefing, it was very clear he mentioned the RTC in the lead up to the Roche order. He literally DID mention Omega Diagnostics by default. This is a big step forward, and a sign that the government is confident enough to bring it up. For me, this is another checkbox ticked, along with a guaranteed order of antibody tests from the government and lots of talk about how important they will be. All moving in the right direction.

Second development ANTIBODY

Promote the company to who? I'll assume that you don't work in companies that adopt tech such as this? I'm confused about how you think this company got the likes of AstraZeneca and Cancer Research to start utilising their product?

Been invested here for about a year now but only recently joined the boards, so hello to the people who I've been reading posts from for the past year. Feels like something's stirring here over the past couple of weeks and we're due some updates soon. Should be an interesting month ahead.

Has become a sea of meaningless ramping and people panicking who know nothing about the stock they are invested in. Also, people are threatening to scalp and beat people up now? Sort yourselves out and decide whether you should really be posting here before you have done any research or got your anger in check. When I initially bought in here about 6 weeks ago, it was mostly knowledgeable people sharing good information, and now it's pointless coming here, so I'm going to stay away from this BB for a bit. I know why I invested here, I'm not panicking. See you all on the other side of a good RNS at some point soon.

Oh how I wish I'd topped up more 2 weeks ago at 14p when I added a little bit to my position. Been waiting for a dip since it broke 16.4p but it doesn't wanna give me that chance.
34p is also my initial target to derisk my initial investment, but that depends on any updates or earnings reports. I may not need to derisk as it might not be much of a risk anymore.
Have to say I enjoy the maturity of conversation on this board, it trumps every other BB of stocks I own.

It just keeps breaking new highs and holding them, such solid movement

Exactly, the Roche and Abbott test only strengthens the case here, as the public learns about antibody tests but also learn the pitfalls of a lab test. That paves the way for the government to say they've appointed an at-home test that's created and manufactured by UK companies.

That post doesn't make any sense? Either way, I'm holding this for 6-12 months. A week or two of odd price action is fine by me.

I don't base my investment decisions on intraday price action, especially not at the moment. It's quite easy to see the potential upside here and just as easy to see the reasons that the SP may not be moving up so quickly.

Claiming that you think it's run its' course when construction has just fired up again with lots of business as one of the first industries to start up again. You haven't provided any thinking about your opinion, it just comes across as, well, a little stupid???

15LIVES - I would love to hear your reasoning behind this. It just sounds like you've picked a number out of thin air?

Thanks for sharing this podcast, very informative. Halfway through now, but great to hear no redundancies (although I never expected that, it's still good to hear) - and lots of strategic plans to move out of this pandemic stronger and into new gaps in the market. Holt comes across very well, should be an interesting 6 months ahead.

Been an odd few days here. Considering the briefing 2 nights ago from the government called on construction hours to be extended - in non-residential areas it can be 24 hours a day as far as I understood it, I expected this to hold 30p very well. Good green morning, hopefully it's just back up from here.

Do you have a link to the article this appears in please?